FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/085930 [Registered on: 29/04/2025] Trial Registered Prospectively
Last Modified On: 23/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Understanding the principle of nidan parivarjan with a focus on diabetes 
Scientific Title of Study   Evaluation of Nidan Parivarjan Siddhant with special reference to Madhumeha  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ambrish Mishra 
Designation  Junior resident 
Affiliation  Banaras Hindu University 
Address  Department of siddhant darshan IMS BHU Varanasi

Varanasi
UTTAR PRADESH
221005
India 
Phone  09415361140  
Fax    
Email  Ambrishmishra1234@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof CS Pandey 
Designation  Former head of department 
Affiliation  Banaras Hindu University 
Address  Department of Siddhant darshan IMS BHU Varanasi

Varanasi
UTTAR PRADESH
221005
India 
Phone  09415361140  
Fax    
Email  cspandey@bhu.ac.in  
 
Details of Contact Person
Public Query
 
Name  Dr Ambrish Mishra 
Designation  Junior resident 
Affiliation  Banaras Hindu University 
Address  Department of siddhant darshan IMS BHU Varanasi


UTTAR PRADESH
221005
India 
Phone  09415361140  
Fax    
Email  Ambrishmishra1234@gmail.com  
 
Source of Monetary or Material Support  
sir sunderlal hospital faculty of Ayurveda Institute of Medical sciences BHU Varanasi 221005 uttar pradesh India 
 
Primary Sponsor  
Name  Faculty of Ayurveda IMS BHU 
Address  Department of Siddhant Darshan, Faculty of Ayurveda, IMS BHU varanasi 221005 uttar pradesh India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
prof cs pandey  Department of Siddhant darshan, Faculty of Ayurveda, IMS BHU Varansi 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ambrish Mishra  Sir Sunderlal Hospital BHU  OPD No 11A, Siddhant Darshan OPD Department of Siddhant Darshan Faculty of Ayurveda IMS BHU Varanasi UTTAR PRADESH
Varanasi
UTTAR PRADESH 
08574729954

Ambrishmishra1234@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E119||Type 2 diabetes mellitus without complications. Ayurveda Condition: MADHUMEHAH/KSHAUDRAMEHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Amlaki, Reference: Charak samhita, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 3 Months, anupAna/sahapAna: No, Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Haridra, Reference: charak chikitsa, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 3 Months, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  . Patients who are having cardinal symptoms of Madhumeha as described in Ayurvedic texts.
. All patients of Type 2 DM (Non insulin dependent).
. patients who have given informed consent
 
 
ExclusionCriteria 
Details   
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Based on subjective and objective criteria
Madhusamam Mutram
Pipasadhikya
Kara-Pada-Suptanga
Swedaadhikya
Alasya
Jatilibhavam kesheshu
Asyamadhurya
Karapadayodaha
Blood investigations- FBS(fasting blood sugar), PPBS(post prandial blood sugar), HbA1C
Urine examination- Routine examination, Microscopic examination


 
3 follow ups with equal interval of 1 month
Total study time will be 3 months
 
 
Secondary Outcome  
Outcome  TimePoints 
B. This study will signify the preventive aspects of Madhumeha as well as will also help in management and reduce the chances of complications in Madhumeha  After giving medication, 3 follow up of 4 weeks will be done.
Total study time will be 3 months
 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   02/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The impact of Nidana Parivarjana in the management of Madhumeha as well as the complementary effects of the same to the pharmacological interventions in Madhumeha will be ascertained within the limitations of the study. This in turn can reduce the over dependence on of existing healthcare system and medicines can help a great deal in framing the present-day Diabetes treatment, with cost effective 
Close